4.8 Article

Gonadotropin-releasing hormone agonists for endometriosis

期刊

NEW ENGLAND JOURNAL OF MEDICINE
卷 359, 期 11, 页码 1136-1142

出版社

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMct0803719

关键词

-

资金

  1. Nobelpharma
  2. Procter Gamble

向作者/读者索取更多资源

A 36- year- old woman presents with long- standing pelvic pain, including dysmenorrhea and pain with intercourse. She has previously received oral contraceptives and depot medroxyprogesterone for presumed endometriosis. This regimen has not relieved her pain, and she has had side effects, including continual abnormal uterine bleeding and fluid retention. She is referred to a reproductive endocrinologist for further investigation and treatment. After a careful review and examination to rule out other explanations for the patient's symptoms, the endocrinologist recommends the use of a gonadotropin- releasing hormone agonist combined with norethindrone acetate as empirical treatment for endometriosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据